Adding a P2Y12 inhibitor does not improve outcomes in COVID-19
Jan 18, 2022
Adding a P2Y12 inhibitor to a therapeutic dose of heparin does not improve outcomes among non-critically ill patients hospitalized for COVID-19.
CDC warns of coming omicron wave
Dec 15, 2021
There was a sevenfold spike in the highly contagious variant’s presence across the nation in just one week.
Adults with IBD show antibody response to mRNA COVID-19 vaccine
Nov 09, 2021
After mRNA COVID-19 vaccination, 99% of patients with inflammatory bowel disease had detectable antibodies regardless of immunocompromising therapies.
More testing of staff linked to drop in COVID-19 cases, deaths at SNFs
Mar 23, 2023
Reductions in COVID-19 cases and deaths among residents at skilled nursing facilities mainly were seen before vaccine availability.
Fourth dose of BNT162b2 offers protection against severe COVID-19
Apr 08, 2022
Protection against COVID-19 did not wane in six weeks after receipt of fourth dose of the Pfizer–BioNTech vaccine; protection against the infection waned.
United Kingdom eases COVID-19 testing rules for international visitors
Jan 06, 2022
The change will be welcome news to people who refrained from traveling for fear they would get stranded in a foreign country.
Fourth dose of BNT162b2 prevents severe COVID-19 in nursing home residents
Jun 27, 2022
Substantial protection against hospitalizations and deaths seen among nursing home residents during the omicron surge.
More clinical benefits of molnupiravir ID’d in COVID-19
Jun 07, 2022
Compared with placebo, normalization of C-reactive protein and oxygen saturation was faster, with improvements seen on day 3 of treatment.
Proportion of asymptomatic SARS-CoV-2 infections unclear
May 27, 2022
Most SARS-CoV-2 infections are not asymptomatic; those with asymptomatic infections are less infectious.
Burden of persistent symptoms high after COVID-19 infection
May 24, 2022
No specific causes of symptoms of postacute sequelae of SARS-CoV-2 infection were identified.